Mant M J, Russell A S, Percy J S, Davis P, Messner H A
Department of Medicine, University of Alberta Hospital, Edmonton, Canada.
J Rheumatol. 1987 Oct;14(5):1026-9.
Three patients who received antithymocyte globulin therapy for severe aplastic anemia due to gold therapy are described. In 2 patients the hemoglobin, white blood cell count and neutrophils were normal and platelet counts exceeded 100 X 10(9)/1 more than 2 years after treatment. The 3rd patient did not respond to antithymocyte globulin or to cyclosporine therapy; subsequent allogeneic bone marrow transplantation resulted in satisfactory engraftment at 12 months. In all 3 patients the arthritis was improved after the episode of marrow aplasia and its treatment. Including these 3 patients, 12 reported patients with severe aplastic anemia due to gold have now been treated with antithymocyte globulin; 8 have shown significant improvement. These results are better than those reported for any other treatment. Antithymocyte globulin may be optimal initial treatment for this serious disorder.
本文描述了3例因金制剂治疗导致严重再生障碍性贫血而接受抗胸腺细胞球蛋白治疗的患者。2例患者在治疗2年多后,血红蛋白、白细胞计数和中性粒细胞正常,血小板计数超过100×10⁹/L。第3例患者对抗胸腺细胞球蛋白和环孢素治疗均无反应;随后的异基因骨髓移植在12个月时获得了满意的植入。所有3例患者的关节炎在再生障碍性贫血发作及其治疗后均有所改善。包括这3例患者在内,目前已有12例报告的因金制剂导致严重再生障碍性贫血的患者接受了抗胸腺细胞球蛋白治疗;8例患者有显著改善。这些结果优于其他任何治疗方法的报告结果。抗胸腺细胞球蛋白可能是这种严重疾病的最佳初始治疗方法。